Bellevue Medical Center
El-Metn 2241
0 studies enrolling now · 1 studies all time
What they study most
HER2-Positive Early Breast Cancer
Studies at this site
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer
— Completed